Ultragenyx Pharmaceutical Inc. (RARE) stock prices updated...
 

Ultragenyx Pharmaceutical Inc. stock price

Ultragenyx Pharmaceutical Inc. latest news:


  • 09/18/2017 06:50:38

    Ultragenyx proposes to buy all Dimension Therapeutics outstanding common stock for $138 mln

    Ultragenyx Pharmaceutical Inc. said early Monday that it has proposed to buy all outstanding common stock of Dimension Therapeutics Inc. for $5.50 per share, or about $138 million. The offer would be offered in cash at close to be effectuated via a tender offer, Ultragenyx said. Dimension Therapeutics shares, which were valued at $4.20 as of Friday's close, were halted in premarket trade Monday. REGENXBIO Inc. said in late August that it planned to buy Dimension Therapeutics for about $3.41 per share, and that the board of directors of both companies had signed on. But Ultragenyx said that its offer represents "premiums of 24% and 48% over the implied value of the all-stock consideration" offered by REGENXBIO. "As such, the proposal would provide Dimension stockholders with an immediate and certain return on their investment in Dimension and constitutes a superior alternative to the REGENXBIO transaction," Ultragenyx said. Dimension Therapeutics shares have surged 236% over the last three months, compared with a 2.8% rise in the S&P 500 . Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/22/2017 14:49:27

    Ultragenyx shares drop as muscle-disease drug study fails

    Ultragenyx Pharmaceutical Inc. shares fell in the extended session Tuesday after the biotech company said a late-stage clinical trial for its severe muscle disease treatment did not reach its goals. Shares of Ultragenyx dropped 10% to $52.96 after hours following a brief halt. The company said its Phase 3 clinical trial for extended-release aceneuramic acid did not significantly improve strength in patients with GNE Myopathy, a rare disease where muscles cannot modify proteins and fats because of an enzyme deficiency. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Ultralife CorporationULBI | Ultrapetrol (Bahamas) LimitedULTR | Ultratech, Inc.UTEK | UMB Financial CorporationUMBF | Umpqua Holdings CorporationUMPQ | Unico American CorporationUNAM | Unilife CorporationUNIS | Union Bankshares CorporationUBSH | Union Bankshares, Inc.UNB | Uni-Pixel, Inc.UNXL |